Original language | English (US) |
---|---|
Pages (from-to) | 395-398 |
Number of pages | 4 |
Journal | American journal of respiratory cell and molecular biology |
Volume | 61 |
Issue number | 3 |
DOIs | |
State | Published - 2019 |
Funding
Supported by German Research Foundation grants SFB-TR84 (project number 114933180, projects B2 and B9), SFB1021 (project number 197785619, project C05), and KFO309 (project number 284237345, projects P2 and P8); the Excellence Cluster Cardio-Pulmonary System/CardioPulmonary Institute (EXC 2026, project number 390649896); National Institutes of Health grants HL-071643 and AG-049665; the German Center for Lung Research; and the German Center for Infection Research. Author Contributions: Conceived and designed the study: C.P., S.P., T.W., and S.H. Performed experiments and analyzed data: C.P., I.K., J.S., M.H., and E.L. Interpreted data and drafted the manuscript: C.P., I.K., S.P., and S.H. Edited the manuscript: J.I.S., I.V., R.E.M., S.P., T.W., and S.H. Supported by National Institutes of Health grants R01HL125583, R01HL130512, R01HL124233, R01HL126596, U01HL089897, U01HL089856, T32HL007427, and P01HL132825. The COPDGene project is also supported by the COPD Foundation through contributions made to an industry advisory board comprised of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Siemens, and Sunovion.
ASJC Scopus subject areas
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Clinical Biochemistry
- Cell Biology